Tuesday, October 13, 2015 1:53:51 AM
The company will host an analyst and investor breakfast on Tuesday, October 13th at 7:00am (PDT) at the W Hotel San Francisco. Management will provide a brief corporate update followed by
physician presentations
On Wednesday, October 14th, Dr. Dimitrios Georgakopoulos PhD, Sunshine Heart’s Chief Scientific Officer, will present hemodynamic data collected from pre-clinical studies and patients implanted with the C-Pulse device during device optimization and from patients with implantable sensors.
http://www.sunshineheart.com/sunshine-heart-to-present-hemodynamic-data-supporting-mechanism-of-action-of-the-c-pulse-system-at-2015-transcatheter-cardiovascular-therapeutics-conference/
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM